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Background: In order to give informed consent for mammography screening, women need to be told the relevant
facts; however, screening information often remains vague because of the worry that detailed information might
deter women from participating in recommended screening programs. Since September 2010, German women
aged 50 to 69 invited for mammography screening have received a new, comprehensive information brochure that
frankly discusses the potential benefit and harm of mammography screening. In contrast, the brochure that was in
use before September 2010 contained little relevant information.
The aim of this study is to compare the impact of the two different brochures on the intention of women to
undergo mammography screening, and to broaden our understanding of the effect that factual information has on
the women’s decision-making.
Methods: This is a controlled questionnaire study comparing knowledge, views and hypothetical preferences of
women aged 48–49 years after receiving the old versus the new information brochure. German GP’s in the region
of North Rhine-Westfalia will be asked by mail and telephone to participate in the study. Eligible women will be
recruited via their general practitioners (GPs) and randomized to groups A (‘new brochure’) and B (‘old brochure’),
with an intended recruitment of 173 participants per group. The study is powered to detect a 15% higher or lower
intention to undergo mammography screening in women informed by the new brochure.
Discussion: This study will contribute to our understanding of the decision-making of women invited to
mammography screening. From both ethical and public health perspectives, it is important to know whether frank,
factual information leads to a change in the intention of women to participate in a recommended breast cancer
screening program.
Trial registration number: DRKS00004271
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Since 2005, all women in Germany between 50 and
69 years of age have been invited to the national
mammography screening program. From the public health
perspective, there is a legitimate interest in achieving a
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distribution, and reproduction in any mediumof participants might decrease considerably if fact- and
figure-based information is given to screening participants,
because the benefit for the individual participant is very
small.
On the other hand, it is an ethical duty to inform people
truthfully and intelligibly about the screening in order to
allow them to make informed decisions. The patients’
right to disclosure of all relevant information for medical
decisions is fixed in the European Charter of Patients’
Rights [1]. The operationalization of this right builds theCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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choice (evidence-based patient choice) patients need
evidence-based patient information (EBPI). This infor-
mation has to include risks, benefits, number needed
to screen, sensitivity, specificity and so on [2]. Further
theoretical input comes from O’Connor’s concept of
decisional conflict describing the weighing of risks and
benefits in case of uncertainty about outcomes [3].
Information brochures are one way of giving information
to patients. The brochure distributed to eligible women
until September 2010, together with the invitation letter
for mammography screening (‘old brochure’), contained
hardly any material relevant to making an informed
decision [4,5]. Following increasing criticism, the ‘old
brochure’ was replaced by a thoroughly revised version
(‘new brochure’) which contains considerably more infor-
mation about the benefits and risks of the screening and
also illustrates the facts with numerical examples [4].
From an informed-consent perspective, this new brochure
can be judged exemplary in patient information for screen-
ing examinations. To our knowledge, neither in Germany
nor in other countries is there any official information
material on screening examinations that informs as
comprehensively as this one [6-9].
Against this background it is very important to know
whether more detailed and comprehensive information will
effect differences in the intention of women to participate
in breast cancer screening. Moreover, we know little about
the role that information brochures play overall in the
decision to participate or not to participate in screening
programs.
Research questions
We wanted to know whether, and to what extent, the
content of the information brochure distributed nationwide
in Germany influences women’s intention to participate
in mammography screening, and whether EBPI-relevant,
transparent information regarding the potential benefits
and harms of early detection screening influences this
intention. In detail, our research questions are:
1. What influence does an information brochure
including relevant facts and figures on the
harms and benefits of mammography screening
(‘new brochure’) have on women’s intention
to take part in screening, compared to a
brochure that mainly promotes the screening
while omitting relevant information
(‘old brochure’)?
2. Do different information brochures lead to different
knowledge about the potential benefits and harms of
mammography screening?
3. Are there any other factors (beside the contents of
brochures) influencing the decision to take part(for example, personal experience with breast cancer,
marital status)?Hypothesis
The two groups (‘new’ versus ‘old brochure’) differ in their
intention to take part in mammography screening.Current status of research
There are only few studies on the topic, and as it is ethically
problematic to perform a study within the context of a real
invitation for screening, the question whether the tested
persons would participate if they were invited has been
asked only hypothetically in those studies.
There are several studies examining decision-making
for mammography screening programs. Some of them
investigate optimized decision aids, others - as we do - look
at information brochures that are in use by national
screening programs [10-15]. Webster et al. performed a
questionnaire study in England in 2006. They interviewed
1,000 women aged 48 to 64 years about their knowledge
and their attitude toward mammography screening (base-
line assessment) [15]. They repeated the questionnaire
study in 2007 with 100 women who were recruited from
the baseline group, this time after having read the recently
implemented information brochure about mammography
screening. The second assessment showed a significant
gain in knowledge [6]. Mathieu et al. investigated the
effect of ‘online decision aids’ for mammography screening
on 321 Australian women aged 70, and subsequently on
38 to 40 years old women. In both studies, the women in
the intervention group - those with the decision aid - had
more knowledge about the screening and showed greater
decision competence than the group without such an
aid, and they refused to participate in screening more
often [14,16]. A non-comparative descriptive study was
performed by Börgermann using an information brochure
for PSA screening: 1,537 men within a preventive check-up
had been interviewed using a questionnaire. Although 82%
of the men felt well informed after they had read the
brochure, their knowledge tested in the questionnaire
was rather poor [17]. In a study by Steckelberg et al. on
decision-making for colonoscopy screening, a specially
produced brochure for such screening containing per-
tinent evidence-based information was compared with
a standard information brochure with regard to willing-
ness, knowledge and attitudes of the interviewees. The
study was performed on the target group (age 50 to 75
yrs). The results showed that the intervention group had
better knowledge; although a ‘positive attitude’ towards
the screening was significantly less common in this
group, no difference in willingness to participate could
be demonstrated [8].
Table 1 Criteria for an informed screening choice and
their consideration in brochure A (‘new’) and B (‘old’)
Criteria Brochure A Brochure B
1. Rate of pathological result of screening Y Ya
2. Benefit of mammography screening Y Y
3. Reduction of mortality by screening Ya N
4. Absolute/relative risk reduction N N
5. Reduction of total mortality N N
6. Sensitivity of screening Y Y
7. Specificity of screening Y N
8. How many women have to be screened to
save one from dying of breast cancer (NNSb)
Ya N
9. Recommendation to self-checking the
breast (BSEc)
Nd Yd
10. Overdiagnosis - early cancer
(How many DCISe are discovered that
would never have any clinical relevance?)
Ya N
11. Rate of false positive results Ya N
12. Increase of operation and radiation
of women who do not benefit
Y N
13. Interval cancer Y Y
14. Earlier diagnosis without delay of death Y N
15. Potential side effects of x-ray N Y
aIncludes specification of figures.
bNNS: number needed to screen.
cBSE: breast self examination.
dStudies have shown that BSE has no effect on the mortality of breast cancer,
therefore a positive recommendation must be judged negatively with view to
an informed choice.
eDCIS: ductal carcinoma in situ.
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This is a controlled two-armed single-blind questionnaire
study. Women will be randomized into two groups: group
A will receive the ‘new brochure’ (Additional file 1) with
facts and figures corresponding to current evidence on out-
come. Group B will receive the ‘old brochure’ (Additional
file 2) with little, merely promoting, information.
We are addressing women aged 48 to 49 yrs, that is, one
or two years before eligibility for mammography screening.
For ethical reasons we did not choose the eligible age, so
as not to influence the immediate decision of the women
regarding participation in screening. Also, women aged
50+ are more likely to have received and studied the
‘new brochure’ already, so the study’s control arm receiving
the ‘old brochure’ would probably have been contaminated.
The women are recruited via their GPs, whom we contact
with a request to participate in the study. Twenty-five of
106 doctors contacted in the North Rhine-Westphalia area
of Germany agreed to participate in the study and to send
us a list of all women of eligible age who had presented to
their practice in the past two years. In Germany, women of
this age group (48 to 49 years) contact their GP about four
times a year on average [18].
To pseudonymize the women, all names are deleted
from the list before it is sent to us, while the internal
practice reference number remains for later identifica-
tion. We then randomly select 24 women from each
practice for inclusion in the study. Randomization is at
patient level, that is, these 24 women are randomized
per practice into two groups; A (‘new brochure’) or B
(‘old brochure’). According to the random allocation,
the women in groups A and B will receive the respective
brochure, a letter, and a uniform questionnaire about
knowledge and intention to take part in a screening.
Closed envelopes which are marked only by the internal
practice reference number are sent to the practices and
from there directly to the women. With the attached
letter they are asked to complete the questionnaire
after reading the brochure and to send it back to us,
without disclosing their identity, for pseudonymous ana-
lysis. The questionnaires contain a reference number that
can only be decoded by the GPs.Instruments
Information brochures
The women receive either the ‘old’ or the ‘new’ information
brochure attached to the invitation for mammography
screening prior to or after the year 2010, respectively.
The ‘old brochure’ promotes the screening and gives
only limited information about facts and figures, whereas
the ‘new brochure’ provides transparent information about
the potential benefits and harms of the screening based on
the available evidence, illustrated by figures (Table 1).Formal description of the two brochures:
The design of information brochures is a scientific issue
of its own [19]; we did not have any influence on the
design of the two brochures. Both brochures appear in
the same standard, on edge flyer format. They both
comprise 12 pages, and none of them contains any
figures or pictograms. A comparing analysis of formal
criteria of the two brochures has not been provided so
far. In our study we did not examine the effects of the
formal and graphical design of the brochures [2].
Questionnaire
The questionnaire employed to elicit the women’s know-
ledge has been developed on the basis of already existing,
partly validated questionnaires [12-15,17] and builds upon
the criteria for relevant knowledge to make an informed
decision [2] (Additional file 3). It contains five questions
on knowledge (one point for every correct answer) [2,14].
Two questions measure the women’s self-assessment of
their knowledge about mammography screening; two
questions are about the perceived relevance of knowledge
for the individual [12]. There is one yes/no question on
Gummersbach et al. Trials 2013, 14:319 Page 4 of 5
http://www.trialsjournal.com/content/14/1/319the intention to participate (primary outcome), combined
with a confidence rating for this decision (six-point scale
from ‘very unsure’ to ‘absolutely sure’). Furthermore, there
is one question each about personal experience with breast
cancer, educational level, age, marital status and native
language, two questions concerning the assessment of the
brochure, and an open question for the participant to
indicate information needs not sufficiently dealt with
in the respective brochure. For secondary analyses we
constructed items on the following topics: preferred
media for support in screening decision, risk perception,
attitudes towards mammography screening.
The questionnaire was pre-tested in 15 women with
regard to comprehensibility, resulting in slight revisions
of item wording and scaling.
Inclusion and exclusion criteria
All women aged 48 or 49 years identified by the partici-
pating practices will be included. This age group has not
yet been invited to a mammography screening and has not
so far made the decision to participate in such screening.
However, the first invitation is imminent, so the subject
matter is already of interest for them. GPs are asked to ex-
clude women from their lists who are not sufficiently fluent
in German, and women with obvious cognitive limitations.
Compliance with the exclusion criteria remains in the
responsibility of the inviting physicians.
Consent and ethical approval
All participants will be asked for informed consent to
participate.
The study was approved by the ethics committee of the
University Hospital, Heinrich-Heine-University of Duesseldorf
(22.02.2012, ref. number 3797) (Additional file 4).
Sample size
At present, the participation rate for mammography
screening in North Rhine-Westphalia, Germany is 53.7%
[20]. We assume that participation in this interview study
is more likely than participation in real screening, and
therefore expect a 60% willingness to take part on mam-
mography screening in the interviews. We judge a group
difference of at least 15 absolute percentage points (that is,
from 60% to 75% or from 60% to 45%) to be relevant. To
detect such differences in the primary analysis with a power
of 80%, 173 study participants per group = 346 participants
have to be included. We expect a response rate of approxi-
mately 50%, so at least 692 women need to be contacted.
Statistical analysis
The primary analysis will include all women who
consented to study participation and gave information on
her intention to participate in a potential mammography
screening (full analysis set). It consists of a likelihood ratiochi-square test of the intention to screening participation
with a two-sided alpha of 5%. As a sensitivity analysis, best
and worst case analyses will be performed in all consenting
women (intention-to-treat population) with different
imputations for missing values. In a second step, a logistic
regression model including potential confounders and
effect modifiers (for example, knowledge) will be fitted
to the data for further explanation of the primary result.
Secondary endpoints (knowledge, self-assessed knowledge,
importance of knowledge, confidence in decision) will be
compared using chi-square tests or Mann–Whitney U
tests, whichever appropriate.
Limitations
A possible influence of differences in the formal design
of the two brochures on the decision to take part in the
screening program is not subject of our examination;
however, the two brochures are formally quite similar.
Trial status
We are currently recruiting participants.
Additional files
Additional file 1: neu mammo_merkblatt.pdf (new brochure).
Additional file 2: alt mammo_merkblatt.pdf (old brochure).
Additional file 3: Fragebogen 2 englisch.doc (questionnaire).
Additional file 4: Statement Ethikkommission.pdf (statement ethics
committee of the university hospital, Heinrich-Heine University of
Duesseldorf).
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